AMN Antikörper (N-Term)
Kurzübersicht für AMN Antikörper (N-Term) (ABIN928304)
Target
Alle AMN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- AMN antibody was raised in rabbit using the N terminal of AMN as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
AMN Blocking Peptide, (ABIN5612047), is also available for use as a blocking control in assays to test for specificity of this AMN antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- AMN (Amnionless (AMN))
-
Andere Bezeichnung
- AMN
-
Hintergrund
- The protein encoded by this gene is a type I transmembrane protein. It is thought to modulate bone morphogenetic protein (BMP) receptor function by serving as an accessory or coreceptor, and thus facilitates or hinders BMP binding. It is known that the mouse AMN gene is expressed in the extraembryonic visceral endoderm layer during gastrulation, but it is found to be mutated in amnionless mouse. The encoded protein has sequence similarity to short gastrulation (Sog) and procollagen IIA proteins in Drosophila. Synonyms: Polyclonal AMN antibody, Anti-AMN antibody, amnionless homolog, mouse antibody, PRO1028 antibody.
-
Pathways
- Lipid Metabolism
Target
-